{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:54:27Z","timestamp":1766138067180,"version":"3.37.3"},"reference-count":8,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2022,8,11]]},"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1136\/thorax-2022-219472","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T17:20:50Z","timestamp":1662052850000},"page":"1159-1160","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Immunotherapy in non-small-cell lung cancer: new data support its use, but some challenges remain"],"prefix":"10.1136","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6633-771X","authenticated-orcid":false,"given":"Allan","family":"Ramos-Esquivel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"2024051320343575000_77.12.1159.1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000236"},{"key":"2024051320343575000_77.12.1159.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215614"},{"key":"2024051320343575000_77.12.1159.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0489"},{"key":"2024051320343575000_77.12.1159.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.06.015"},{"key":"2024051320343575000_77.12.1159.5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jval.2017.07.011","article-title":"Do surrogate endpoints better correlate with overall survival in studies that did not allow for crossover or reported balanced Postprogression treatments? an application in advanced non-small cell lung cancer","volume":"21","author":"Hashim","year":"2018","journal-title":"Value Health"},{"key":"2024051320343575000_77.12.1159.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.07.034"},{"key":"2024051320343575000_77.12.1159.7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2625"},{"key":"2024051320343575000_77.12.1159.8","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.jtho.2016.07.017","article-title":"Relationship between overall survival and response or progression-free survival in advanced non-small cell lung cancer patients treated with anti-PD-1\/PD-L1 antibodies","volume":"11","author":"Shukuya","year":"2016","journal-title":"J Thorac Oncol"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-219472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:50:42Z","timestamp":1715658642000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-219472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":8,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,11,15]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/thorax-2022-219472"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-219472","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"type":"print","value":"0040-6376"},{"type":"electronic","value":"1468-3296"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}